** ASX-listed shares of Australia's AVITA Medical AVH.AX RCEL.O rise as much as 7.9% to A$4.11
** Stock set for strongest trading session since early Nov and hits highest since Dec. 12
** Co says U.S. Food and Drug Administration granted approval for its Recell Go mini product
** The product is a mini disposable cartridge designed to treat smaller wounds
** Stock had fallen 11.2% this year, as of last close
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.